Skip to main content
SpringerLink
Log in

Comparative Expression of the Mitotic Regulators SAK and PLK in Colorectal Cancer

  • ORIGINAL ARTICLES
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Disruption of normal mechanisms for cell cycle regulation is important in carcinogenesis. SAK and PLK are members of the polo family of serine threonine kinases, which in lower organisms have been shown to be required for the precise regulation of mitosis. Studies of human polo family members have focused on PLK, which has been found to be overexpressed in several tumor types, with the degree of overexpression correlating with adverse clinical outcome. However, PLK expression had not previously been analyzed in colorectal cancer. SAK, a polo family member with unique properties, had not been systematically studied in any tumor type.

Methods: In this study, SAK expression was evaluated in a series of sporadic human colorectal cancer specimens (n = 74) and compared with that of PLK. Expression was assessed by reverse transcription-polymerase chain reaction.

Results: In the majority of cases, both SAK and PLK were more highly expressed in tumor tissue than in adjacent normal intestinal mucosa. Levels of SAK and PLK expression in tumor relative to paired normal mucosa correlated directly with patient age and with each other but did not correlate with tumor stage. These results suggest a mechanism for augmented disruption of mitotic regulation in older patients.

Conclusions: The polo family mitotic regulators SAK and PLK are both aberrantly expressed in colorectal cancer. The potential prognostic significance of SAK and PLK expression in colorectal cancer will be evaluated in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Glover DM, Ohkura H, Tavares A. Polo kinase: the choreographer of the mitotic stage? J Cell Biol 1996; 135: 1681–4.

    Article  PubMed  CAS  Google Scholar 

  2. Hudson JW,ChenL-Y, Fode C, Binkert C, Dennis J. Sak kinase gene structure and transcriptional regulation. Gene 2000; 241: 65–73.

    Article  Google Scholar 

  3. Lane HA, Nigg EA. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol 1996; 135: 1701–13.

    Article  PubMed  CAS  Google Scholar 

  4. Fode C, Motro B, Yousefi S, Heffernan M, Dennis J. Sak, a murine protein-serine/threonine kinase that is related to the Drosophila polo kinase and involved in cell proliferation. Proc Natl Acad Sci U S A 1994; 91: 6388–92.

    Article  PubMed  CAS  Google Scholar 

  5. Hudson JW, Kozarova A, Cheung P, et al. Late mitotic failure in mice lacking Sak, a polo-like kinase. Curr Biol 2001; 11: 441–6.

    Article  PubMed  CAS  Google Scholar 

  6. Mundt KE, Golsteyn R, Lane HA, Nigg EA. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem Biophys Res Commun 1997; 239: 377–85.

    Article  PubMed  CAS  Google Scholar 

  7. Smith MR, Wilson ML, Hamanaka R, et al. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun 1997; 234: 397–405.

    Article  PubMed  CAS  Google Scholar 

  8. Fode C, Binkert C, Dennis J. Constitutive expression of murine Sak-a suppresses cell growth and induces multinucleation. Mol Cell Biol 1996; 16: 4665–72.

    PubMed  CAS  Google Scholar 

  9. Wolf G, Elez R, Doermer A, et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997; 14: 543–9.

    Article  PubMed  CAS  Google Scholar 

  10. Knecht R, Elez R, Oechler M, Solbach C,von von Ilberg C, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res 1999; 59: 2794–7.

    PubMed  CAS  Google Scholar 

  11. Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S, Niho Y. Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol 1999; 15: 687–92.

    PubMed  CAS  Google Scholar 

  12. Ozcelik H, ToMD, Couture J, Bull SB, Andrulis IL. Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. Int J Cancer 1998; 77: 1–6.

    Article  PubMed  CAS  Google Scholar 

  13. Yuan J, Stutte HJ, Hock B, Stutte HJ, Rübsamen-Waigmann H, Strebhardt K. Polo-like kinase, a novel marker for cellular proliferation. Am J Pathol 1997; 150: 1165–72.

    PubMed  CAS  Google Scholar 

  14. LyDH, Lockhart DJ, Lerner RA, Schultz PG. Mitotic misregulation and human aging. Science 2000; 287: 2486–92.

    Article  PubMed  CAS  Google Scholar 

  15. Ponz de Leon M, Sacchetti C, Sassatelli R, Zanghieri G, Roncucci L, Scalmati A. Evidence for the existence of different types of large bowel tumor: suggestions from the clinical data of a population-based registry. J Surg Oncol 1990; 44: 35–43.

    Article  PubMed  CAS  Google Scholar 

  16. Weisburger JH, Wynder EL. Etiology of colorectal cancer with particular emphasis on mechanisms of action and prevention. In: De Vita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. New York: Lippincott, 1987.

    Google Scholar 

  17. Kern SE, Fearon ER, Tersmette KWF, et al. Clinical and pathological association with allelic loss in colorectal carcinoma. JAMA 1989; 261: 3099–103.

    Article  PubMed  CAS  Google Scholar 

  18. Kouri M, Pyrhonen S, Mecklin JP, et al. The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer 1990; 62: 976–81.

    Article  PubMed  CAS  Google Scholar 

  19. Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD. The influence of tumor cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985; 72: 828–30.

    Article  PubMed  CAS  Google Scholar 

  20. Roncucci L, Fante R, Losi L, et al. Survival for colon and rectal cancer in a population-based cancer registry. Eur J Cancer 1996; 32A: 295–302.

    Article  PubMed  CAS  Google Scholar 

  21. Carlon CA, Fabris G, Arslan-Pagnini C, Pluchinotta AM, Chinelli E, Carniato S. Prognostic correlations of operable carcinoma of the rectum. Dis Colon Rectum 1985; 28: 47–50.

    Article  PubMed  CAS  Google Scholar 

  22. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986; 10: 437–59.

    Article  PubMed  CAS  Google Scholar 

  23. Galitski T, Saldanha AJ, Styles CA, Lander ES, Fink GR. Ploidy regulation of gene expression. Science 1999; 285: 251–4.

    Article  PubMed  CAS  Google Scholar 

  24. Rooney P, Murray GI, Stevenson DAJ, Haites NE, Cassidy J, McLeod HL. Comparative genomic hybridization and chromosomal instability in solid tumors. Br J Cancer 1999; 80: 862–73.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Samuel Lunenfeld Research Institute and Mount Sinai Hospital, University of Toronto, Toronto, Canada

    Jennifer C. Macmillan MD, MSc & Carol J. Swallow MD, PhD

  2. Department of Molecular and Medical Genetics, Samuel Lunenfeld Research Institute and Mount Sinai Hospital, University of Toronto, Toronto, Canada

    John W. Hudson PhD & James W. Dennis PhD

  3. Department of Clinical Epidemiology, Samuel Lunenfeld Research Institute and Mount Sinai Hospital, University of Toronto, Toronto, Canada

    Shelley Bull PhD

  4. 600 University Avenue, Suite 1224, Toronto, Ontario, Canada M5G 1X5

    Carol J. Swallow MD, PhD

Authors
  1. Jennifer C. Macmillan MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John W. Hudson PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shelley Bull PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James W. Dennis PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carol J. Swallow MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Presented at the 54th Annual Meeting of the Society of Surgical Oncology, Washington, DC, from March 15–18 2001.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macmillan, J.C., Hudson, J.W., Bull, S. et al. Comparative Expression of the Mitotic Regulators SAK and PLK in Colorectal Cancer. Ann Surg Oncol 8, 729–740 (2001). https://doi.org/10.1007/s10434-001-0729-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0729-6

Key Words:

Search

Navigation